Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Palmoplantaris Pustulosis

3,3',5-triiodothyroacetic acid has been researched along with Palmoplantaris Pustulosis in 1 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Research Excerpts

ExcerptRelevanceReference
"TriAc in the dosage and formulation studied was safe but no more effective than placebo in treating plaque psoriasis."2.71Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial. ( Carlsson, B; Törmä, H; Vahlquist, A, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vahlquist, A1
Törmä, H1
Carlsson, B1

Trials

1 trial available for 3,3',5-triiodothyroacetic acid and Palmoplantaris Pustulosis

ArticleYear
Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial.
    The British journal of dermatology, 2004, Volume: 151, Issue:2

    Topics: Administration, Topical; Adult; Dermatologic Agents; Double-Blind Method; Female; Humans; Male; Midd

2004